Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsui

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
Arthritis and Rheumatism|January 20, 1998
MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypesN Tsuchiya, M Shiota, S Moriyama, et al.
Chemical & Pharmaceutical Bulletin|March 8, 2000
Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419S Tabuchi, H Ito, H Sogabe, et al.
British Journal of Haematology|August 1, 1990
Effect of recombinant human erythropoietin on anticancer drug-induced anaemiaT Matsumoto, K Endoh, K Kamisango, et al.
Cancer Research|February 1, 1993
Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptorY Kanakura, H Sugahara, H Mitsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1992
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo]K Akamatsu, K Endo, T Tsunenari, et al.
Leukemia|April 1, 1997
The p53-deficient hemopoietic stem cells: their resistance to radiation-apoptosis, but lasted transientlyY Hirabayashi, M Matsuda, T Matumura, et al.
Anticancer Research|July 1, 1989
Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II)K Endoh, K Akamatsu, T Matsumoto, et al.
British Journal of Cancer|July 1, 1991
Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomerT Matsumoto, K Endoh, K Akamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1990
[Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line]K Akamatsu, K Endo, T Matsumoto, et al.
Bone Marrow Transplantation|July 1, 1989
Ureteric obstruction after allogeneic bone marrow transplantation: an unusual complicationA Hiraoka, H Teshima, H Mitsui, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
Arthritis and Rheumatism|January 20, 1998
MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypesN Tsuchiya, M Shiota, S Moriyama, et al.
Chemical & Pharmaceutical Bulletin|March 8, 2000
Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419S Tabuchi, H Ito, H Sogabe, et al.
British Journal of Haematology|August 1, 1990
Effect of recombinant human erythropoietin on anticancer drug-induced anaemiaT Matsumoto, K Endoh, K Kamisango, et al.
Cancer Research|February 1, 1993
Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptorY Kanakura, H Sugahara, H Mitsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1992
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo]K Akamatsu, K Endo, T Tsunenari, et al.
Leukemia|April 1, 1997
The p53-deficient hemopoietic stem cells: their resistance to radiation-apoptosis, but lasted transientlyY Hirabayashi, M Matsuda, T Matumura, et al.
Anticancer Research|July 1, 1989
Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II)K Endoh, K Akamatsu, T Matsumoto, et al.
British Journal of Cancer|July 1, 1991
Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomerT Matsumoto, K Endoh, K Akamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1990
[Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line]K Akamatsu, K Endo, T Matsumoto, et al.
Bone Marrow Transplantation|July 1, 1989
Ureteric obstruction after allogeneic bone marrow transplantation: an unusual complicationA Hiraoka, H Teshima, H Mitsui, et al.
Pageof 22